KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short-term Investments (2016 - 2026)

Bristol Myers Squibb has reported Short-term Investments over the past 18 years, most recently at $912.0 million for Q1 2026.

  • Quarterly Short-term Investments rose 0.55% to $912.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $912.0 million through Mar 2026, up 0.55% year-over-year, with the annual reading at $464.0 million for FY2025, 9.55% down from the prior year.
  • Short-term Investments was $912.0 million for Q1 2026 at Bristol Myers Squibb, up from $464.0 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $2.6 billion in Q1 2022 and troughed at $130.0 million in Q4 2022.
  • The 5-year median for Short-term Investments is $513.0 million (2024), against an average of $799.9 million.
  • Year-over-year, Short-term Investments plummeted 95.65% in 2022 and then surged 527.69% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $130.0 million in 2022, then surged by 527.69% to $816.0 million in 2023, then crashed by 37.13% to $513.0 million in 2024, then dropped by 9.55% to $464.0 million in 2025, then soared by 96.55% to $912.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Short-term Investments are $912.0 million (Q1 2026), $464.0 million (Q4 2025), and $776.0 million (Q3 2025).